Ryan Kahn, MD, MHS
@RyanKahnMD1
Followers
2K
Following
1K
Statuses
251
Gynecologic Oncology Fellow at Memorial Sloan Kettering Cancer Center 👨⚕️👨🔬 views are my own
New York, NY
Joined October 2020
RT @TeamOvary_MSK: Congratulations to @RyanKahnMD1 for this wonderful recognition from IJGC! @TeamEndo_MSK @TeamOvary_MSK
0
3
0
1
0
5
RT @RiosDoriaMD: Traveled halfway across the world for #IGCS2024! This is my first @IGCSociety Annual Meeting & I look forward to meeting…
0
6
0
RT @TeamOvary_MSK: Excited to share an innovative pre-operative scoring system, the BLOODS score, to help identify patients with ovarian ca…
0
2
0
Awesome experience with @Medtronic this weekend with a comprehensive Gyn Onc anatomy lab. Seen here dissecting out the obturator nerve all to its L2-L4 nerve roots
1
0
18
Amazing showing by Team GYN at the 2024 @MSKCancerCenter @Cycle4Survival Had a blast raising money while dancing and cycling to help beat rare cancers
0
2
20
RT @IJGConline: #2024SpecialIssue Extra-abdominal cytoreductive techniques in #ovariancancer how far can (should) we go? @RyanKahnMD1 @dch…
0
12
0
RT @TeamOvary_MSK: Amazing showing by Team Ovary @Cycle4Survival to raise money for research and awareness for rare cancers! @BillzamMD @su…
0
8
0
0
1
4
Featured by @MSKLibrary: Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on pat...
0
0
8
RT @IJGConline: 🚨 Review on #Cardiophrenic lymph nodes in advanced #OvarianCancer by our Editorial Fellows @nagustiga @BonaldoGiulio @RyanK…
0
23
0
RT @agz_eriksson: 🌟Excellent study by @TeamOvary_MSK 🏥Centralization of #cancercare ➡️🔝survival @ESGO_society Quality Indicators are creat…
0
2
0
@CommunityGynOnc @gynoncjnls @sushmitabg @dchimd @TeamOvary_MSK @MSKCancerCenter @SGO_org @IJGConline @IGCSociety @RyanEllisMD Thank you @CommunityGynOnc for your insight. The 13% traveling >50 miles was calculated out of the ~10,500 women who went to low volume centers during our study (not the overall # in your question). So would affect a significant number (87%) within this cohort, ~9,100 women
1
0
0
@JenniferOgilvi @YingLiu88 @MSKCancerCenter @SGO_org We explored HR genes and compared with BRCA1/2-associated and WT OCs. Rates of biallelic alterations differed, high rates among germline PVs in BRIP1, PALB2, RAD51B, RAD51C, and RAD51D; however, HRD phenotype varied with enrichment in PALB2 and RAD51B/C/D compared to BRIP1.
0
0
0
RT @YingLiu88: Finally out! Implications for PARPi therapy and RAD51B as an OC predisposition gene. Congrats @RyanKahnMD1 & @TeamOvary_MSK.…
0
2
0